Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Aftertreated solid synthetic organic polymer
Reexamination Certificate
2006-08-22
2006-08-22
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Aftertreated solid synthetic organic polymer
C514S772000, C514S772300, C424S450000, C424S489000
Reexamination Certificate
active
07094810
ABSTRACT:
The present invention relates to a pharmaceutical composition of a biologically active agent and a block copolymer composed of a poly(ethylene oxide) forming hydrophilic segment and a poly(butyl (alkyl)acrylate-co-(alkyl)acrylic acid) that is capable of forming supramolecular assemblies or micelles under favourable conditions. The supramolecular assemblies or micelles formed from said polymers associate or dissociate reversibly upon changes in the environmental pH. The pharmaceutical compositions of the present invention contain hydrophobic drugs, cations or polycationic compounds, which can be delivered to the body by oral route or other routes of administration.
REFERENCES:
patent: 4870005 (1989-09-01), Akiyoshi et al.
patent: 5492996 (1996-02-01), Dang et al.
patent: 5510103 (1996-04-01), Yokoyama et al.
patent: 5620850 (1997-04-01), Bamdad et al.
patent: 5656611 (1997-08-01), Kabanov et al.
patent: 5693751 (1997-12-01), Sakurai et al.
patent: 5702717 (1997-12-01), Cha et al.
patent: 5770627 (1998-06-01), Inoue et al.
patent: 5786387 (1998-07-01), Watanabe et al.
patent: 5840319 (1998-11-01), Alakhov et al.
patent: 5908777 (1999-06-01), Lee et al.
patent: 5925720 (1999-07-01), Kataoka et al.
patent: 5929177 (1999-07-01), Kataoka et al.
patent: 5939453 (1999-08-01), Heller et al.
patent: 5955509 (1999-09-01), Webber et al.
patent: 6217912 (2001-04-01), Park et al.
patent: 6221959 (2001-04-01), Kabanov et al.
patent: 6372203 (2002-04-01), Allwohn et al.
patent: 6440743 (2002-08-01), Kabanov et al.
patent: 6491901 (2002-12-01), Gers-Barlag et al.
patent: 2002/0187199 (2002-12-01), Ranger et al.
patent: 0 639 592 (1993-08-01), None
patent: 0963758 (1999-12-01), None
patent: 141 1843 (1975-08-01), None
patent: WO96/21036 (1996-07-01), None
patent: WO96/32841 (1996-10-01), None
patent: WO97/33737 (1997-09-01), None
patent: WO98/19710 (1998-05-01), None
patent: WO98/37902 (1998-09-01), None
patent: WO01/87227 (2001-11-01), None
patent: WO2004/035013 (2004-04-01), None
B. Lele et al, “Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages”, Journal of Controlled Release, 69:237-248 (2000).
V. Coessens et al, “Functional polymers by atom transfer radical polymerization”, Prog. Polym. Sci., 26:337-377 (2001).
Y. Kakizawa et al, “Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond”, J. Am. Chem. Soc., 121:11247-11248 (1999).
K. Kataoka et al, “Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block cvopolymer in physiological saline”, Macromolecules, 29:8556-8557 (1996).
Scholz et al, “A novel reactive polymeric micelle with aldehyde groups on its surface”, Macromolecules, 28:7295-7297 (1995).
Lee et al, “Synthesis and micellar characterization of amphiphilic diblock copolymers based on poly(2-ethyl-2-oxazoline) and aliphatic polyesters”, Macromolecules, 32:1847-1852 (1999).
Benahmed et al, “Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide)”, Pharmaceut. Res., 18(3):323-328 (2001).
K. Kataoka et al, “Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance”, Journal of Controlled Release, 64:143-153 (2000).
K. Kataoka et al, “Design of nanoscopic vehicles for drug targeting based on micellization of amphiphilic block copolymers”, J.M.S.-Pure Appl. Chem., A31(11):1759-1769 (1994).
L. Zhang et al, “Multiple morphologies of “crew-cut” aggregates of polystyrene-b-poly(acrylic acid) block copolymers”, Science, 268:1728-1731 (1995).
C. Allen et al, “Nano-engineering block copolymer aggregates for drug delivery”, Colloids and Surfaces b: Biointerfaces, 16:1-24 (1999).
C-L. Zhao et al, “Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers”, Langmuir, 6:514-516 (1990).
A. Kabanov et al, “The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles”, FEBS Letters, 258(2):343-345 (1989).
G. Kwon et al, “Polymeric micelles as new drug carriers”, Advanced Drug Delivery Reviews, 21:107-116 (1996).
Inoue et al, “An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs”, J. Controlled Release, 51:221-229 (1998).
M. Heller et al, “Co9nformational stability of lyophilized PEGylated proteins in a phase-separating system”, Journal of Pharmaceutical Sciences, 88(1):58-64 (1999).
L. Stryer, in Biochemistry, Chapter 7, pp. 154-155, fourth edition, W. H. Freeman and Company , New York (1995).
M-C. Jones et al, “Polymeric micelles-a new generation of colloidal drug carriers”, European Journal of Pharmaceutics and Biopharmaceutics, 48:101-111 (1999).
S. Fullerton et al, “Molecular and population genetic analysis of allelic sequence diversity at the human beta-globin locus”, Proc. Natl. Acad. Sci. USA, 91(5):1805-1809 (1994), (GenBank Accession No. AAA21101, published Aug. 6, 1994—retrieved from http://www.ncbi.nlm.nih.gov:80/entrez/viewer.fcgi?db=protein&val=532507 on Mar. 30, 2004).
S. Liebhaber et al, “Cloning and complete nucleotide sequence of human 5′-alpha-globin gene”, Proc. Natl. Acad. Sci. USA, 77(12):7054-7058 (1980), (GenBank Accession No. CAA23748 published Apr. 24, 1993—retrieved from http://www.ncbi.nlm.nih.gov:80/entrez/viewer.fcgi?db=protein&val=51618 on Mar. 30, 2004).
C. Freiji-Larsson et al, “Polyurethane surfaces modified by amphiphilic polymers: effects on protein adsorption”, Biomaterials, 21:307-315 (2000).
Leroux Jean-Christophe
Sant Vinayak
Kishore Gollamudi S.
Labopharm Inc.
McHale & Slavin P.A.
Silverman Eric
LandOfFree
pH-sensitive block copolymers for pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with pH-sensitive block copolymers for pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and pH-sensitive block copolymers for pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3622233